جستجوی استاد راهنمای دانشگاهی

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +۳ مورد دیگر

Maria J. Redondo is a Professor at Baylor College of Medicine and leads the Maria J. Redondo Lab at Texas Children’s Hospital, focusing on Type 1 Diabetes across four core areas: Genetics for prediction models and trial candidate selection Heterogeneity in diabetes pathogenesis Prevention through clinical trials Atypical Diabetes and Racial/Ethnic Influences Research Trends: Her recent articles emphasize genetic risk modeling, BMI correlations in pediatric diabetes, and HLA studies. The work integrates autoimmunity , metabolic research , and epidemiological analysis . Scientific Awards: Elected to the Society for Pediatric Research (2014) JDRF Early Career Development Award (2002) JDRF Postdoctoral Fellowship (2000) Immunology of Diabetes Society Junior Investigator Award (1998) Mentoring: Dr. Redondo mentors fellows and students in projects like COVID-19 and Diabetes and Racial Differences in Insulin Pump Uptake , with grants from NIH , Medtronic , and Hemsley Charitable Trust .

• Type 1 Diabetes
• Genetics of Autoimmune Diseases
• Diabetes Heterogeneity
• +۳ مورد دیگر

Pierette Appasamy is a Lecturer in the Department of Biology at Chatham University’s College of Arts & Sciences. With a Ph.D. in Anatomy & Developmental Biology from Thomas Jefferson University, she has over three decades of experience in immunology research and education. Her career spans roles at the University of Pittsburgh School of Medicine, NIH-funded research, and current work at Chatham since 2007. B.S., Biology, cum laude, Xavier University (1982) Ph.D., Anatomy & Developmental Biology, Thomas Jefferson University (1988) Post-Doctoral Fellowship, Immunology, University of Pennsylvania (1987-1990) Her research focuses on the evolution and development of gamma delta T cells , IL-7 signaling pathways in amphibians, and psychosocial-immune interactions in college students . She employs Xenopus frogs as a model organism to study non-conventional lymphocyte biology and wound healing immunology. Recent publications highlight her work on cytokine evolution and stress-immune-microbiome dynamics , with collaborations at the University of Pittsburgh’s Center for Medicine and the Microbiome. Her pedagogical innovations include role-playing and analogies to enhance immunology education. NIH R29 Grant (Principal Investigator) NIH R01 Grant (Co-Investigator) MacArthur Foundation Grant (Yale Subcontract) American Cancer Society Grant Chatham University Technology Fellowship Award American Association of Immunologists Travel Grant She mentors students in laboratory research and serves as Chatham’s Pre-Med Advisor. Her lab combines molecular techniques, tadpole thymus microsurgery, and behavioral studies to explore immunological questions with clinical relevance.

• Development and evolution of the immune system
• Skin and mucosal immune responses
• Gamma delta T cell biology
• +۷ مورد دیگر

Dr. Channakeshava S. Umeshappa is a faculty member in the Department of Microbiology & Immunology and Department of Pediatrics at Dalhousie University, Canada . He holds a PhD in Immunology from the University of Saskatchewan and completed postdoctoral training at the University of Calgary. Education : DVM (Karnataka Veterinary Animal and Fisheries Sciences University, India), MVSc (Indian Veterinary Research Institute, India), PhD (University of Saskatchewan, Canada) Research Interests : Dr. Umeshappa’s program focuses on immunoregulation in chronic diseases , particularly autoimmunity and cancer. His lab employs genetically modified murine models , omics , synthetic biology , flow cytometry , and imaging to develop immunotherapies. His work emphasizes interdisciplinary collaboration with clinicians and scientists. Article Trends : Recent publications highlight nanomedicine applications in autoimmune liver disease (e.g., peptide-MHC nanomedicines, invariant NKT cell reprogramming) and cancer therapy (e.g., laser-responsive nanoparticles, tumor-to-lymph gels). Studies span immuno-informatics , cell signaling , and clinical outcomes analysis.

• Human Immunology
• Inflammation
• Autoimmunity
• +۳ مورد دیگر

Ashley Moseman serves as an Assistant Professor of Integrative Immunobiology and Assistant Professor of Cell Biology at Duke University School of Medicine. She holds significant affiliations as a Faculty Network Member of the Duke Institute for Brain Sciences and a Member of the Duke Cancer Institute. Her pioneering research examines the delicate balance between neuronal function and immune protection at the olfactory neuroepithelial barrier, where sensory neurons directly interface with the external environment while protecting the central nervous system from pathogens. Dr. Moseman completed her Ph.D. at Harvard University in 2011, establishing the foundation for her interdisciplinary career at the intersection of immunology and neuroscience. Her research program focuses on understanding how immunological surveillance operates at the unique olfactory barrier, where neurons must contact the external environment to perform chemosensory functions while preventing pathogens from entering the CNS. The Moseman Lab employs cutting-edge multiphoton intravital imaging to visualize immune responses in vivo, revealing dynamic cellular interactions during viral infections and responses to pathogens like Naegleria fowleri. Current projects investigate olfactory barrier mechanisms, neuroimmune crosstalk, host-pathogen dynamics, and immune responses to deadly neurotropic pathogens. Analysis of Dr. Moseman's publication record demonstrates a cohesive research trajectory centered on neuroimmunology and mucosal defense mechanisms. Her work spans fundamental immunological processes, host-pathogen interactions at neural interfaces, and translational applications for understanding neurological complications of infections. A significant portion of her recent research addresses SARS-CoV-2-related olfactory dysfunction and the immunological basis of pathogen invasion through the olfactory system into the central nervous system. Dr. Moseman has secured substantial research funding including 'Using tissue-specific Naegleria opportunism to dissect olfactory immunity' (2025-2030), 'Characterizing olfactory plasma cell dynamics and survival niche within the upper airway' (2024-2029), and the 'Advanced Immunobiology Training Program for Surgeons' (2019-2029). She actively contributes to graduate education through the Medical Scientist Training Program (2022-2027) and teaches advanced immunology courses including IMMUNOL 736 and IMMUNOL 494. The Moseman Lab represents a leading center for neuroimmunology research, utilizing in vivo imaging to visualize immune responses within the central nervous system. Their work has significant implications for understanding how pathogens breach neurological barriers and how the immune system protects the brain while preserving essential sensory functions, with potential applications for treating neurological infections and inflammatory conditions.

• CNS immunity
• Olfactory barrier immunology
• Neuroimmunology
• +۵ مورد دیگر

Dr. Siyang Zheng is a Professor at Carnegie Mellon University (CMU) in the Departments of Biomedical Engineering and Electrical and Computer Engineering. He leads the Micro & Nano Integrated Biosystem (MINIBio) Lab, focusing on developing micro/nano technologies for precision healthcare. His research bridges materials science, device engineering, and biomedicine, with key areas including liquid biopsy technologies for cancer diagnosis, nanomaterials for therapeutics, and virus detection platforms. Dr. Zheng holds over 50 peer-reviewed publications and 15 patents, and has been honored with the NIH Director's New Innovator Award and the American Cancer Society’s Research Scholar Award. Education: B.S., Biological Sciences and Biotechnology, Tsinghua University, China, 1996 M.S., Electrical Engineering, The Pennsylvania State University, 2000 Ph.D., Electrical Engineering, California Institute of Technology, 2007 Postdoctoral Research, Electrical Engineering, California Institute of Technology, 2008 Research Interests: Microfluidics/BioMEMS, nano-biotechnology, cancer diagnosis/treatment, infectious diseases, implantable devices. His lab pioneers technologies like lipid nanoprobes for EV isolation, flexible micro spring arrays for CTC enrichment, and carbon nanotube-based virus detection systems. Articles Trends: Recent work emphasizes liquid biopsy advancements, extracellular vesicle analysis, and nanomedicine innovations. Key themes include ultrafast protein digestion systems, drug delivery via nanomaterials, and point-of-care diagnostics for viral pathogens. Awards: NIH Director's New Innovator Award American Cancer Society (ACS) Research Scholar Award Advising & Grants: Supervised over 20 students (PhD, M.S., undergrad), with notable alumni in academia and industry. Active in translational research, including collaborations on clinical trials and device commercialization. Labs & Teams: MINIBio Lab at CMU fosters interdisciplinary projects with clinicians, engineers, and industrial partners. Current focus areas include thymus-on-chip models, metal-organic frameworks for drug delivery, and AI-driven biomarker discovery.

• Biomedical Engineering
• Nanotechnology
• Microfluidics
• +۷ مورد دیگر

Dr. Maryam Roudbary is an Adjunct Senior Lecturer at the Westmead Clinical School, part of the Sydney Medical School, University of Sydney. She joined the Sydney Infectious Diseases Institute (Sydney ID) in 2023 as a researcher affiliated with the University of Sydney and employed by NSW Health and Research Network as a Senior Researcher in Mycology. Previously, she served as an Associate Professor at Iran University of Medical Sciences (2015–2022), leading research projects and supervising Master’s and PhD students in medical mycology and fungal infections. Her PhD in Medical Mycology focused on antifungal resistance mechanisms and new therapeutic strategies. Current research priorities include developing novel antifungal agents against drug-resistant fungi, understanding resistance mechanisms, and addressing challenges outlined in the WHO’s 2022 Fungal Priority Pathogen List. She is an editor for several mycology journals and co-authored The Book of Fungal Pathogens (2022). Roudbary’s work spans epidemiological studies, clinical sampling, and collaborations in One Health AMR initiatives. She leads projects on fungal diversity exploration (e.g., Vietnam citizen science initiatives) and evaluates natural compounds (e.g., thymus extracts, nanoparticles) for antifungal efficacy. Recent grants include a 2025 project on antifungal peptide-based therapeutics. Her research emphasizes biofilm formation in filamentous fungi, Candida species pathogenesis, and fungal co-infections in immunocompromised patients, including those with severe COVID-19. Key findings include the prevalence of azole-resistant Candida species in Iran and the role of gene expression (e.g., CDR1 , HWP1 ) in drug resistance. Roudbary’s contributions include over 100 peer-reviewed articles, grants focusing on antifungal innovation, and active roles in international mycology networks. She bridges clinical and research domains through translational studies targeting critical fungal health challenges.

• Medical Mycology
• Antimicrobial Resistance
• Infectious Diseases
• +۴ مورد دیگر

Ellen Robey is a Professor of Immunology and Molecular Medicine at the University of California, Berkeley, serving as Division Head of the IMM Division. Her research focuses on signaling pathways controlling T cell fate decisions, using mouse models to study T cell development and immune responses, including mechanisms of thymic selection and CD4/CD8 lineage commitment. She employs 2-photon imaging to analyze T cell behavior in situ, particularly during parasitic infections like Toxoplasma gondii . Robey’s lab investigates how self-reactivity influences thymic selection timing and develops collaborative projects combining multi-omics approaches with spatial and temporal analyses of thymic development. Key research areas include understanding negative/positive selection mechanisms in the thymus, immune response dynamics during chronic infections, and the role of unconventional T cell subsets recognizing non-classical MHC molecules. The lab has pioneered studies on Qa1-restricted T cells and their role in host defense against pathogens. Her work bridges basic immunology with cutting-edge imaging and systems biology tools to unravel complex immune processes. Lab collaborations include projects with Nir Yosef and Aaron Streets to create high-resolution thymic developmental maps using single-cell multi-omics. Current efforts also explore how ERAAP downregulation alters antigen presentation, influencing T cell responses. The Robey Lab emphasizes diversity in its team, fostering an inclusive environment for scientific innovation.

• Immunology
• Molecular Biology
• Cell Biology
• +۳ مورد دیگر

Ole Petter Ottersen is a Professor at the University of Oslo’s Faculty of Medicine, affiliated with the Institute of Basic Medical Sciences. He previously served as Rector of the University of Oslo (2009–2017) and President of Karolinska Institutet (2017–2023). Ottersen holds dual roles as a Visiting Professor at Charité – Universitätsmedizin Berlin’s Global Health Institute and an affiliated member of Karolinska’s Department of Neuroscience and Department of Global Public Health. He is also Vice President of the Virchow Foundation and chairs the Lancet Commission on Global Governance for Health 2.0. His career spans academic leadership, research coordination, and international health policy advocacy. Education: He earned an M.D. (1980) and Ph.D. in Neuroscience (1982) from the University of Oslo. Ottersen has held academic positions including Research Fellow (1978–1983), Associate Professor (1983–1992), and has coordinated prestigious EU and Nordic grants. His research priorities include academic quality, internationalization, innovation, and dissemination. Research interests focus on molecular neuroscience (e.g., aquaporin-4 channels in brain water dynamics) and global health governance. His work bridges basic science and policy, addressing health inequity, pandemic preparedness, and sustainable healthcare. Recent publications emphasize systemic approaches to global crises, vaccine equity, and interdisciplinary solutions for health challenges. Ottersen has received the Anders Jahre Medical Prize (twice), the Lundbeck Nordic Research Prize, and honorary doctorates from multiple institutions. His awards include France’s Ordre national du Mérite (2019) and Japan’s Order of the Rising Sun (2023). He has led prize committees, including the Kavli Prize in Neuroscience. He has coordinated major national and international grants, such as Norway’s Functional Genomics Program (FUGE) and the EU’s Biomed and NeuroImage projects. His advisory roles include the European Research Council (ERC), WHO-related initiatives, and boards like Oslo University Hospital and NordForsk. Ottersen’s teaching spans medical students since 1976, covering neurobiology, histology, and anatomy. Key initiatives include founding the Guild of European Research-Intensive Universities and leading the Lancet Commission on Global Governance for Health. He collaborates with institutions like EMBL-Norway, Africa CDC, and the Global Virus Network, emphasizing intersectoral action and equitable global health systems.

• Molecular Neuroscience
• Global Health Governance
• Aquaporin Channels
• +۵ مورد دیگر

Christopher A. J. Roman serves as Associate Professor and Chairman of Cell Biology at SUNY Downstate Health Sciences University's College of Medicine, with a dual appointment as Associate Professor of Medicine. His career spans over three decades with continuous contributions to immunology and lymphocyte biology. His academic credentials include: B.A. in Biochemistry from Harvard University (1984) Ph.D. in Biological Chemistry from UCLA (1991) Post-Doctoral Fellowships at The Rockefeller University (1992-1994) and MIT (1994-1998) Roman's research centers on B lymphocyte biology with critical focus on immunological tolerance mechanisms preventing autoimmune diseases like systemic lupus erythematosus (SLE). His laboratory investigates transcriptional regulation through Mitf family factors (Mitf, TFE3, TFEB) in lymphocyte function and lipid metabolism pathways involving SMS2 in germinal center tolerance. Employing transgenic mouse models, primary cell cultures, flow cytometry, and immunohistochemistry, his work bridges molecular mechanisms with clinical applications in autoimmunity. Collaborations with Rheumatology and Allergy/Immunology divisions enable direct clinical translation of findings. Analysis of his publication history reveals consistent progression from foundational B cell development studies to current mechanistic investigations of tolerance pathways, with increasing emphasis on transcriptional networks and metabolic regulation in autoimmune pathogenesis. His distinguished recognition includes: LGBTQ+ Advocacy Award (2024) Outstanding Educator in Foundations of Medicine (2018) Excellence in Mentoring Award (2018) SUNY Chancellor's Award for Faculty Service (2008) Lupus Research Institute Novel Project Award (2006) Henry Kunkel Society membership (since 2010) Roman maintains active mentorship of graduate students including MD/PhD candidates Milena Rodriquez (2023), Nanda Lahiri (2020), and Abhimanyu Amarnani (2020). His research program receives sustained funding from NIH institutes (NIAID, NIAMS, ORWH), Lupus Research Alliance, and Lupus Foundation of America. Current collaborative projects with Dr. Chongmin Huan explore SMS2 pathways for lupus therapeutics. He directs a specialized laboratory investigating B cell tolerance mechanisms while leading institutional initiatives including Pathways HEAL (Health Equity Advocacy Leadership) and LGBTQIA+ Health programs.

• Immunology
• B Cell Biology
• Autoimmune Diseases
• +۳ مورد دیگر

Prof. Soner Doğan is a Professor at Yeditepe University's Faculty of Medicine, Department of Medical Biology. He holds a PhD in Medical Biology from the University of Minnesota and a Bachelor's in Veterinary Science from Ankara University. His research bridges oncology, epigenetics, and metabolic regulation, with a focus on breast cancer mechanisms and calorie restriction. Research interests span: Breast Cancer Pathobiology : Investigating leptin/adiponectin signaling and epigenetic modifications in tumor development. Calorie Restriction : Examining intermittent vs. chronic dietary interventions for cancer prevention and aging. Aging and Frailty : Identifying biomarkers and molecular pathways in age-related diseases using murine models. His publications emphasize molecular oncology, with recurring themes in adipokine signaling, DNA methylation, and transcriptomic profiling. Articles frequently utilize transgenic mouse models and RNA-seq to explore metabolic and immune interactions in cancer. Awards & Honors: Professional Development Grant, Education Minnesota Foundation AICR Scholarship for Cancer Research Conference Advising & Grants : Supervised 11+ Master's/PhD theses on topics like nanoparticle drug delivery and epigenetic regulation. Secured major grants including TÜBİTAK 1001 (€395K) for breast cancer epigenetics and COST Action CA17129 for cardiovascular transcriptomics. Affiliations : Leads projects at Yeditepe’s molecular biology labs and collaborates internationally (e.g., EU-CardioRNA COST Action). Holds administrative roles as Department Coordinator and Ethics Committee member.

• Breast Cancer
• Calorie Restriction
• Molecular Biology
• +۳ مورد دیگر

Dr. Anna Cai is a Lecturer in the Department of Applied Mathematics within the School of Mathematics & Statistics at the University of New South Wales (UNSW), a position she has held since 2011. Prior to this, she served as a postdoctoral researcher and lecturer at the University of California, Irvine from 2007 to 2011. Her educational background: Ph.D., The University of Melbourne, 2008 B.Sc. (First Class Honours), The University of Melbourne, 2004 Dr. Cai's research centers on Mathematical Biology , with specialization in cell migration dynamics , developmental pattern formation , and robustness in biological systems . She employs multi-scale mathematical modeling and stochastic analysis to investigate phenomena ranging from wound healing to zebrafish hindbrain development. Her work bridges theoretical mathematics with experimental biology to decode fundamental mechanisms governing cellular behavior and morphogenesis. Analysis of her 11 publications (2006-2015) reveals an evolutionary trajectory from foundational work on cell migration mechanics to sophisticated studies of developmental robustness. Early research established mathematical frameworks for wound-healing assays and immune cell dynamics, while later work pioneered noise-driven pattern formation models in zebrafish. A unifying thread is her focus on how biological systems maintain precision despite environmental fluctuations. Administrative responsibilities include: Applied representative on the postgraduate review committee UNSW study abroad and exchange course authority Current teaching assignments: MATH2121: Theory and Applications of Differential Equations MATH2018: Engineering Mathematics 2D Prior courses taught: MATH3041: Mathematical Modeling for Real World Systems MATH6781: Biomathematics

• Mathematical Biology
• Biomathematics
• Mathematical Modeling
• +۳ مورد دیگر

Alea Mills is a Professor at Cold Spring Harbor Laboratory, leading the Mills Laboratory and serving as Faculty Head of the Animal Shared Resource within the Cancer Center. She is affiliated with the Cancer Center, the Stanley Institute for Cognitive Genomics, and the Gene Regulation and Inheritance departments. Mills earned her Ph.D. in 1997 from the University of California, Irvine. Her research focuses on the genetic and epigenetic mechanisms underlying cancer, aging, and neurodevelopmental disorders like autism. Central to her work is the study of chromatin regulation and its role in diseases such as glioblastoma, squamous cell carcinoma, and senescence. Key projects include investigating the tumor suppressor gene CHD5, the p63 protein family, and chromatin remodeling complexes in cancer progression. Recent publications highlight advancements in glioblastoma treatment through epigenetic reprogramming, the role of ΔNp63α in cancer stemness, and the impact of chromatin modifiers like BRD8 and EZH2. Mills has also contributed to understanding autism using mouse models of 16p11.2 microdeletion. In 2012, she was honored with the 'Woman of the Year in Health/Medicine' award. Her lab collaborates extensively, with a focus on translating basic research into therapeutic strategies. Current efforts include exploring novel targets for cancer and neurodegenerative diseases, alongside investigating the molecular basis of cellular senescence and aging.

• Cancer Biology
• Aging
• Epigenetics
• +۵ مورد دیگر

Dr. Erika Tsingos serves as an Assistant Professor in the Department of Theoretical Biology and Bioinformatics at Utrecht University's Faculty of Science. She leads the Computational Animal Development Group focusing on computational approaches to developmental biology questions. Her research spans animal developmental biology with emphasis on Computer modeling of cell fate decisions Pattern formation in tissues Cell migration mechanics Thymus development and leukemogenesis C. elegans developmental precision She employs diverse modeling approaches including ordinary differential equations and multiscale cell-based models using cellular Potts or center-based formalisms. Analysis of her 15 most recent publications reveals strong focus on computational modeling of developmental processes, particularly examining extracellular matrix effects on cell migration, thymic niche architecture in leukemia development, and precise cell fate specification in C. elegans. Her work consistently bridges computational modeling with experimental validation through collaborations. Scientific recognition includes: NWO grant VI.Veni.222.323 for research on extracellular matrix effects on cell migration Dr. Tsingos actively mentors the next generation of computational biologists through supervision of postdoctoral researchers and students. Current team members include Benjamin Planterose Jiménez (post-doc modeling C. elegans development), Saber Shakibi (post-doc developing hybrid migration models), and Nikki Landzaat (Master's student studying mesoderm cell state transitions). Former students include Bidayatul Masulah (Master's in Applied Mathematics) and Heleen van Osch (bachelor researcher). Her research group operates within Utrecht University's Department of Theoretical Biology and Bioinformatics, collaborating extensively with the Ten Tusscher group and experimental labs. Current projects investigate how extracellular matrix affects cell migration phenotypes in cancer and the molecular control mechanisms behind C. elegans' precise cell division patterns.

• Computational Biology
• Animal Developmental Biology
• Multiscale Modeling
• +۴ مورد دیگر

Ursula Andrea Gonzales Barron is a principal investigator affiliated with the Instituto Politécnico de Bragança (IPB), where she focuses on microbial risk assessment, biopreservation, and predictive microbiology. Her research spans food safety, particularly in dairy and fermented meat products, and she holds the Investigadora RENACYT (Nivel I) award from the Consejo Nacional de Ciencia y Tecnología e Innovación Tecnológica (2019). Current research projects include "Biointervenções e Modelação de Risco" (FCT-funded, 2019-2023) and "Agro-ecossistemas Frágeis Produtivos" (FCT, 2023-2026). Key scientific contributions: Pathogens-in-Foods (PIF) open-access database, meta-regression models for microbial inactivation, and risk assessment frameworks for Listeria monocytogenes in dairy/meat products. 2024-2025 publications address microbial dynamics in cheeses, antimicrobial plant extracts, and fermented food safety standards in Mediterranean regions. Her work combines experimental microbiology with statistical and computational approaches to model microbial behavior, optimize preservation techniques, and inform food safety policies. She collaborates on European food safety initiatives and develops biopreservation strategies using lactic acid bacteria and plant-derived compounds. Scientific awards: Investigadora RENACYT (Grupo Carlos Monge Medrano - Nivel I, 2019) Grants: FCT funding for agro-pastoral sustainability (2023-2026) FCT funding for Mediterranean fermented food safety (2019-2023)

• Food Safety
• Microbial Risk Assessment
• Biopreservation
• +۳ مورد دیگر